Mintz Levin Advises Chiasma, Inc. in $44 Million Series C Financing
1/10/2007
Boston, MA - Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. - a full-service, 480-lawyer AmLaw 100 firm with offices throughout the U.S. and in the U.K., announced that it represented Chiasma, Inc., in its $44 million Series C financing to fund clinical testing and develop technologies for the enhanced oral delivery of proteins and small molecules. The financing was led by MPM Capital, a global investment management firm focused solely on life sciences investing. Shibboleth served as Chiasma's Israeli counsel in the financing. Chiasma is a privately held company based in Boston, MA with a research subsidiary in Jerusalem, Israel.
The Mintz Levin attorneys representing Chiasma in the financing are Jeff Wiesen, Dean Zioze, and Tim Slavin of the Business and Finance Section.
Mintz Levin is an AmLaw 100 law firm with offices in the US and the UK. The firm has exceptional depth in a broad range of practice areas, but our clients recognize that what sets us apart from other law firms is our industry focus. By truly understanding business drivers and industry trends, we are able to provide our clients with more than just legal advice. We provide legal solutions to our clients' business issues. Since 1933, our lawyers have represented entrepreneurs, emerging growth companies, government agencies, and leaders in primary industries that include Life Sciences/Biotechnology; Technology & Communications; Financial Services & Insurance; Healthcare; Real Estate, Hospitality & Construction; and Retail & Consumer Products. Our practical knowledge combined with our industry expertise enables us to provide our clients with enterprise legal advice that gives their business a competitive advantage in the marketplace.
